Company Filing History:
1 out of 64 
1 out of 4 Years Active: 2020
Title: **Innovative Contributions of Zengle Zhou in Pharmaceutical Chemistry**
Introduction
Zengle Zhou is a prominent inventor based in Linhai, China, known for his significant contributions to pharmaceutical chemistry. With one patent to his name, his work specifically focuses on the preparation of a crucial intermediate used in the synthesis of pregabalin, a medication primarily utilized for the treatment of neuropathic pain and epilepsy.
Latest Patents
Zhou holds a patent for a method for preparing a pregabalin intermediate known as 3-isobutylglutaric acid monoamide. This inventive method outlines a systematic approach that includes several steps: combining 3-isobutylglutaric acid with urea in an organic solvent, heating and refluxing the mixture, and subsequently adjusting pH levels through specific chemical reactions. Overall, the steps culminate in a crystallization process that yields the required monoamide, showcasing his innovative approach to pharmaceutical synthesis.
Career Highlights
During his career, Zengle Zhou has been associated with notable companies in the pharmaceutical industry, particularly Zhejiang Huahai Pharmaceuticals Co., Ltd. and Zhejiang Huahai Zhicheng Pharmaceutical Co., Ltd. His role in these companies has been pivotal, particularly in the research and development sectors, contributing to advancements in drug synthesis and formulation.
Collaborations
Zhou has collaborated with a variety of professionals throughout his career, including coworkers such as Pan Guo and Musong Liu. These collaborations reflect a synergistic approach to innovation in pharmaceuticals, whereby the combined efforts often lead to breakthroughs in therapeutic methods and products.
Conclusion
Zengle Zhou's contributions to the field of pharmaceutical chemistry through his patent for the preparation of a pregabalin intermediate emphasize the importance of innovation in healthcare. As he continues his work in the industry, his past experiences and collaborative efforts are likely to pave the way for further advancements, enhancing the effectiveness of treatments available to patients worldwide.